Colorpak Indonesia Tbk PT

Colorpak Indonesia Tbk PT maintains a strong liquidity position, with cash and equivalents amounting to 251 billion IDR, representing 30.7% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is 2.98%, which is below the industry median of 5.2%, but its current ratio of 2.68 suggests a solid short-term liquidity buffer.

Profitability metrics indicate a relatively modest performance. The company's return on equity (ROE) is 1.34%, and return on assets (ROA) is 0.88%, both below the industry median of 3.5% and 2.1%, respectively. The net margin is 3.5%, which is in line with the industry median of 3.4%.

The company's revenue is concentrated in Indonesia, with no disclosed international operations. It operates in a single business segment, which is typical for firms in the specialty chemicals industry. The lack of geographic or segment diversification increases exposure to local economic and regulatory conditions.

Looking ahead, the company is projected to grow revenue by 4.2% in the current fiscal year and 3.8% in the next fiscal year. This growth is slightly below the industry median of 5.1% and 4.9%, respectively. The company's capital expenditure is negative, indicating asset sales or reduced investment, which may affect long-term growth potential.

Risk factors are minimal in the short term, with low liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags. However, the high price-to-earnings ratio of 67.18 suggests potential overvaluation, and the operating cash flow is negative at -16.3 billion IDR, which could signal underlying operational inefficiencies.

Recent filings and transcripts do not indicate any major strategic shifts or operational disruptions. The company's 10-K filing highlights continued focus on cost optimization and market expansion within Indonesia. No significant earnings call transcripts or regulatory filings have been flagged for unusual activity.

Net income grew 21.5% year-over-year to IDR 68.2 billion, demonstrating strong profitability expansion.

Free cash flow surged 51.5% to IDR 31.5 billion, indicating robust cash generation capabilities.

Revenue increased 7.2% to IDR 979.3 billion, reflecting consistent top-line growth momentum.

Operating income rose 25.5% to IDR 78.2 billion, highlighting improved operational efficiency.

Long-term debt decreased to IDR 51.9 billion, suggesting a strengthening balance sheet position.

Operating margin of 3.5% remains significantly below the 6.0% median for specialty chemicals peers.

Return on equity of 1.3% trails the 3.9% cohort median, indicating weak capital efficiency.

Net margin of 3.5% underperforms the 4.5% industry median, signaling pricing or cost pressures.

Cash conversion ratio of -2.26 places the company in the bottom quartile of its peer group.

Return on assets of 0.9% is low, suggesting limited ability to generate profit from total assets.